Sagittarius Life Science Corp (TPEX:3205)

Taiwan · Delayed Price · Currency is TWD

44.35

-0.45 (-1.00%)

Nov 13, 2026, 1:30 PM CST

Market Cap	3.00B -7.6%
Revenue (ttm)	467.69M +4.9%
Net Income	-16.47M
EPS	-0.24
Shares Out	67.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	71,005
Open	44.80
Previous Close	44.80
Day's Range	44.35 - 45.10
52-Week Range	40.85 - 67.00
Beta	0.29
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 20, 2026

About Sagittarius Life Science

Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology, as well as meat products. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1998

Employees 112

Stock Exchange Taipei Exchange

Ticker Symbol 3205

Full Company Profile

Financial Performance

In 2025, Sagittarius Life Science's revenue was 346.08 million, a decrease of -26.01% compared to the previous year's 467.75 million. Losses were -49.56 million, 2.13% more than in 2024.

Financial Statements